ATS Automation Tooling Systems - PV-Zulieferer und PHOTOWATT-Eigner

eröffnet am 17.07.09 19:42:58 von
neuester Beitrag 24.06.21 15:13:39 von

Beitrag zu dieser Diskussion schreiben

  • 1
  • 4

Begriffe und/oder Benutzer



 Ja Nein
24.06.21 15:13:39
Beitrag Nr. 35 ()
Antwort auf Beitrag Nr.: 64.763.440 von faultcode am 14.08.20 13:43:42
ATS Automation Tooling Systems | 23,40 €
14.08.20 13:43:42
Beitrag Nr. 34 ()
Antwort auf Beitrag Nr.: 57.734.620 von faultcode am 10.05.18 15:42:58

Included in our Q1 orders was our previously announced $65 million program for the design, build and delivery of two automated systems that will enabled the production of up to 10 million units per month of critical components for point of care test kits that can be used to detect COVID-19. I'm pleased to report that our team is on track to meet this very aggressive delivery schedule.

CC Q2:…
ATS Automation Tooling Systems | 13,00 €
1 Antwort
20.12.18 13:47:06
Beitrag Nr. 33 ()
ATS to Acquire a Leading Systems Provider to the Radiopharmaceutical and Pharmaceutical Markets

CAMBRIDGE, ON, Dec. 19, 2018 /CNW/ -

ATS Automation Tooling Systems Inc. (TSX: ATA) ("ATS" or the "Company"), an industry-leading automation solutions provider, today announced it has entered into a definitive agreement to acquire Comecer S.p.A. ("Comecer"), a leader in the design, engineering, manufacture and servicing of advanced aseptic containment and processing systems for the nuclear medicine and pharmaceutical industries.

"Comecer is a proven, high-quality business that brings new and complementary capabilities, customer relationships and specialized talent to ATS," said Andrew Hider, CEO of ATS. "Its addition will strengthen our customer offering in both pharma and biopharma, while adding an innovative new platform in radiopharmaceuticals. These are growing markets with desirable characteristics including stringent quality standards and regulations and where there is a high consequence of failure. We look forward to welcoming Comecer to the ATS family."

Comecer generates approximately 55% of its annual sales to customers in the radiopharmaceutical market, where it supplies specialized radiation shielding systems used by customers in the production, handling, and dispensing of radiopharmaceutical drugs. Applications for this type of equipment include the diagnosis and therapeutic treatment of a number of conditions including various forms of cancer and cardiovascular disorders. The balance of Comecer's sales are derived from equipment to support the aseptic processing, filling and handling of specialized pharmaceuticals as well as isolator and incubator equipment used in advanced therapy medicinal production (ATMP), a regenerative cell therapy that uses patient cells to grow new tissues.

Comecer was established in 1974, and today has approximately 320 skilled employees, the majority of whom work at its main production site in Castel-Bolognese, Italy. The main production site is the home of Comecer's research and development centre. Comecer also has a technical and assembly centre in Joure, Netherlands, and sales and service offices in North America, Europe and Asia.

The total cash purchase price for the acquisition will be 113 million Euro, subject to working capital and other adjustments. The Company will fund the acquisition primarily from cash on hand and its credit facilities. The transaction is expected to close in the first calendar quarter of 2019, subject to customary closing conditions.

For the 2018 calendar year, Comecer is expected to generate revenues of approximately 67 million Euro, with a low double-digit EBITDA margin. In fiscal 2020 (period beginning April 1, 2019), ATS expects adjusted earnings per share accretion in the mid-single digit percentage range as a result of the transaction. Earnings per share are expected to be diluted in the short-term due to the incremental amortization of Order Backlog and other intangible assets as a result of business combination accounting adjustments. Excluding the impact of business combination accounting, the Company expects the return on invested capital associated with this acquisition to achieve double digits by year five post-acquisition.

Integration of Comecer will target revenue synergies and will include the deployment of the ATS Business Model (ABM) which is expected to enable improvements in project management, operations, supply chain management and product life cycle management.

Comecer will continue to be led by its CEO, Alessia Zanelli. "We are very pleased to be joining ATS to continue the next phase of Comecer's growth," said Ms. Zanelli. "By combining ATS and Comecer, we will create a premier player in the radiopharma, pharma and ATMP markets. This will be a tremendous benefit to our customers and a great opportunity for our talented employees. This agreement confirms the potential of our capabilities and will enhance our globally recognized 'made-in-Italy' expertise."
10.05.18 15:42:58
Beitrag Nr. 32 ()
- ist ein bischen teuer momentan als zyklischer Industrieausstatter.
- ein bischen viel Schulden seit den Übernahmen der letzten Jahre für meinen Geschmack.

--> scheint eine M&A-Maschine zu sein.

--> Zukunft hat das -- keine Frage.

--> AR2017

=> man sieht life sciences ist ein Schwerpunkt -- aber auch, dass es da Schwankungen, teilweise beträchtlicher Art, gibt:

business year ist 1.4. -- 31.3. --> AR2018 müsste also bald erscheinen ;)
2 Antworten
24.11.17 12:26:14
Beitrag Nr. 31 ()
what's another year...
13.12.16 10:15:32
Beitrag Nr. 30 ()
Antwort auf Beitrag Nr.: 52.016.735 von R-BgO am 19.03.16 10:32:08
schätze dass es hier um First Solar geht:
ATS provides update in relation to customer program on hold

CAMBRIDGE, ON, Dec. 12, 2016 /CNW/ - ATS Automation Tooling Systems Inc. (TSX: ATA) ("ATS" or the "Company") today provided an update in relation to a program that was put on hold by a customer, which impacted approximately $70 million of Order Backlog.

As reported in the Company's Management's Discussion & Analysis for the three months ended October 2, 2016 ("MD&A"), the customer had placed the program on hold subsequent to the end of the Company's second fiscal quarter, following rapid changes in their market which caused them to re-evaluate their product road map. The customer has now formally cancelled the program. The expected impact of the hold/cancellation on the Company for the third fiscal quarter was previously disclosed in the MD&A.

Going forward, ATS has been engaged by the customer to repurpose those parts of the equipment already completed that can be used by the customer in the manufacture of its next-generation product. Based on consultations with the customer, ATS expects to be invited to bid on and potentially participate in the provision of additional equipment to manufacture this next generation of product. The customer has advised that it expects to begin placing orders in early-to-mid calendar 2017.
19.03.16 10:32:08
Beitrag Nr. 29 ()
wieder günstig geworden
1 Antwort
08.07.14 10:06:11
Beitrag Nr. 28 ()
...sie kaufen gern in D:

ATS to acquire leading global automation services and solutions provider M+W Process Automation

CAMBRIDGE, ON, July 8, 2014 /CNW/ - ATS Automation Tooling Systems Inc. (TSX:ATA) ("ATS" or the "Company") today announced it has entered into a definitive agreement to acquire all shares of M+W Process Automation GmbH and ProFocus LLC, collectively M+W PA, a leading global provider of engineering-based automation services and solutions focused on the control, performance monitoring and measurement of critical production processes.

Headquartered in Germany and established 28 years ago, M+W PA addresses the needs of a wide spectrum of manufacturing and process-based industries including automotive, pharmaceutical, biotechnology, chemicals, oil & gas and food with services that include consulting, system engineering, integration, lifecycle management, process control and manufacturing execution systems, as well as enterprise programs, where M+W PA acts as the main automation contractor ("MAC").

The acquisition is aligned with ATS's stated strategy of scaling its position in the global automation market by adding to its services and life-cycle management capabilities across several core elements of the customer value chain. The addition of M+W PA is expected to enhance growth opportunities in both new markets and with existing customers.

"M+W PA's capabilities complement ATS's solutions in strategic customer markets and open new opportunities in several attractive industries," said Anthony Caputo, ATS Chief Executive Officer. "We welcome M+W PA's highly skilled people, global and local customers, high value service offerings, scale and worldwide presence to our automation business and look forward to continued successful collaboration with M+W Group."

M+W PA's workforce of 1,000, including approximately 750 engineers, serves customers from 51 locations in 16 countries around the world, and is led by a highly experienced management team based in Europe and the U.S. As part of ATS, M+W PA is expected to continue to enhance its portfolio, serve existing M+W PA and ATS customers and build new customer relationships together with ATS.

"We are pleased that our automation business is becoming part of ATS," said Dr. Olaf Berlien, CEO of M+W Group. "ATS is ideally suited to maximize the business area's potential for further worldwide growth. As we will be focusing more on our core business the change of ownership will be very beneficial both for M+W and all employees of the automation business."

In calendar 2013, M+W PA had revenues of approximately €166 million and Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA") of approximately €20 million. Over the past three years, M+W PA's revenues have grown organically at an average annual rate of approximately 19%. Sales by industry segment in 2013 were 41% automotive, 26% chemicals, 13% pharmaceuticals and biotechnology, 3% oil & gas and 17% other industries including food and beverage, water, wastewater, consumer care, paper, metal and semiconductor. Europe accounted for approximately 70% of global sales, North America 27% and Asia 3%. In calendar 2013, M+W PA's order bookings were €188 million, and at the end of May 2014 it had approximately €120 million of backlog.

Subsequent to the completion of the transaction, the Company expects M+W PA to benefit from the adoption of ATS best practices in approach to market, key account management, front-end-of-the-business processes, performance management and corporate strategy. M+W PA's significant capability and market position is expected to benefit ATS and its strategy to grow its business. The Company expects meaningful revenue synergies through an expanded ATS offering, which will now include M+W PA's process controls, software integration, MES, remote monitoring, lifecycle management, modeling and simulation capabilities. M+W PA provides an imbedded engineering, service and sales force, with early insight into customer preferences, developments, problems and programs, allowing M+W PA to act as first responders for post-automation services and equipment maintenance. M+W PA is expected to have increased opportunity to expand its MAC offering by utilizing ATS on a subcontractor basis to address capability gaps across a number of industries. Further, both ATS and M+W PA are expected to have opportunities to engage customers on a more comprehensive basis. Cost synergies are expected to be nominal.

The purchase price based on enterprise value of approximately €248 million (CDN $362 million at current exchange rates) is subject to net debt and working capital adjustments and will be funded from a new fully committed C$600 million credit facility underwritten by The Bank of Nova Scotia and The Toronto-Dominion Bank to be available at closing. With net assets of approximately $20 million, management expects that $342 million of the purchase price will be allocated to goodwill (approximately 60% to 65%) and intangibles (approximately 35% to 40%), subject to completion of the purchase price allocation, which may take up to one year to complete subsequent to transaction closing. Amortization of intangibles is expected to be $10 million to $14 million per annum. In addition, the first six months after acquisition will include substantially all of the amortization of acquired backlog which is expected to be in the $7 million to $10 million range.

On a pre-synergy basis, we expect the following:

Dilution at the Earnings per Share ("EPS") level in the high single digits assuming two quarters of inclusion of M+W PA's results in fiscal 2015, due to the incremental amortization of backlog which is not expected to continue beyond fiscal 2015;
In fiscal 2016, EPS accretion in the high single digits;
On a Cash Flow per Share basis, in fiscal 2015 we expect immediate accretion, in the high single digits; and
Cash Flow per Share accretion in fiscal 2016 is expected to be in the mid teens.
ATS expects to complete the acquisition by the end of September 2014, subject to customary closing conditions, including applicable antitrust approvals.

TD Securities Inc. and Joh. Berenberg, Gossler & Ko. KG Berenberg Bank are acting as financial advisors to ATS. Freshfield Bruckhaus Deringer LLP and Borden Ladner Gervais LLP are acting as legal counsel to ATS.
02.09.13 09:32:33
Beitrag Nr. 27 ()
ATS Automation to acquire a leading pharmaceutical and personal care tube filling and cartoning machinery group

CAMBRIDGE, ON, Sept. 1, 2013 /CNW/ - ATS Automation Tooling Systems Inc. (TSX:ATA) ("ATS" or the "Company") today announced that it has entered into a definitive agreement to acquire all shares of IWK Verpackungstecknik GmbH as well as OYSTAR IWK USA, Inc. ("IWK"), a leader in technology driven high performance tube filling and cartoning machinery for the pharmaceutical and personal care industries.

The acquisition of IWK aligns with ATS's stated strategy of scaling its leading position in the global automation market and enhancing growth opportunities, particularly in strategic customer segments and with technology leadership. IWK is expected to add core capability in primary packaging (tube fillers) and secondary packaging (cartoners), which management expects can be leveraged into other markets ATS currently serves. IWK brings new relationships with key pharmaceutical and personal care customers, which management expects will improve ATS's position in the Life Sciences and Consumer Products sectors. IWK also allows ATS to consider future acquisition possibilities that would be a strategic fit with IWK to provide the Company with deep capabilities across several core elements of the customer value chain.

"We welcome the addition of IWK's highly skilled people, customers, complementary technologies, scale and worldwide presence to our world leading automation business," said Anthony Caputo, ATS Chief Executive Officer. "This acquisition significantly enhances our capability, and deepens our involvement with two attractive customer segments, pharmaceuticals and consumer products."

Headquartered in Germany, and established 120 years ago, IWK engineers, assembles and markets primary packaging and secondary packaging machinery and provides services, for blue-chip companies and local customers around the world. As part of ATS, IWK will continue to enhance its portfolio and serve customers under its own brand.

IWK's approximately 420 employees are based at production facilities near Karlsruhe, Germany and Bangkok, Thailand, and at sales/services centres in the US, Europe and Southeast Asia.

In calendar 2012, IWK had revenues of approximately €82 million and Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA") of approximately €11 million. Sales to customers in the pharmaceuticals and personal care sectors evenly account for over 90% of IWK worldwide revenues. New equipment systems and standard automation each account for approximately 30% of total revenues, with services activity accounting for the remaining 40% of total revenues. European and North American markets each account for approximately a third of revenues, Asia 25%, and the balance largely represented by South America.

The purchase price is approximately €103 million (CDN $144 million at current exchange rates), subject to net debt and working capital adjustments which is expected to result in net cash paid of approximately €95 million, funded substantially from the Company's cash on hand. For its first full year within ATS, IWK is expected to contribute approximately $120 million in revenues and approximately $18 million in EBITDA. The Company expects approximately 50% of the purchase price will be allocated to goodwill. ATS expects to complete the acquisition in the third quarter of fiscal 2014, subject to customary closing conditions, including applicable antitrust approvals. The acquisition is expected to be immediately accretive to Earnings Per Share (EPS) and Cash Flow Per Share (CFPS). Based on current financial results and near term expectations, the Company expects the transaction to contribute approximately 7 cents per share to EPS and approximately 19 cents per share to CFPS for FY2015.
29.03.12 16:01:57
Beitrag Nr. 26 ()
habe meine guckposi heute verkauft

  • 1
  • 4
 DurchsuchenBeitrag schreiben

ATS Automation Tooling Systems - PV-Zulieferer und PHOTOWATT-Eigner